# Сопутствующие статьи по теме Biotech

Новостной центр HTX предлагает последние статьи и углубленный анализ по "Biotech", охватывающие рыночные тренды, новости проектов, развитие технологий и политику регулирования в криптоиндустрии.

Two Acquisitions in One Day: OpenAI Buys 'Narrative', Anthropic Buys 'Barriers'

On April 2, OpenAI and Anthropic each announced an acquisition, reflecting their divergent strategies as both target an IPO by late 2026. OpenAI acquired tech talk show TBPN to shape public AI discourse and support its revenue base, which is 60% consumer-driven from ChatGPT subscriptions. In contrast, Anthropic purchased AI biotech startup Coefficient Bio for approximately $400 million in stock, continuing its focused strategy of deepening enterprise capabilities, particularly in high-switching-cost sectors like life sciences. Over the past three years, OpenAI completed 15 acquisitions across diverse fields including hardware, media, and healthcare, spending over $7.7 billion on disclosed deals, such as the $6.5 billion purchase of Jony Ive’s AI hardware firm. Anthropic made only three acquisitions, each precisely strengthening its product stack: Bun for coding infrastructure, Vercept for autonomous agents, and now Coefficient Bio for biotech R&D pipelines. Anthropic’s enterprise-focused revenue (80% of total) drives its strategy to lock in clients with vertical integration, as seen in its sequenced moves into life sciences and healthcare. Meanwhile, with a higher reliance on consumer subscriptions, OpenAI is investing in narrative influence—TBPN aims to boost ad revenue and steer public AI conversation. Both companies are on accelerated IPO paths: Anthropic eyeing a $60+ billion offering led by Goldman Sachs and JPMorgan, and OpenAI targeting a ~$1 trillion valuation. Their acquisitions underscore distinct priorities—Anthropic builds industry-specific moats, while OpenAI amplifies its public story.

marsbit04/03 10:07

Two Acquisitions in One Day: OpenAI Buys 'Narrative', Anthropic Buys 'Barriers'

marsbit04/03 10:07

OpenAI Bets on 'Robot Army': 23-Year-Old Prodigy Wins Favor from Sam Altman

While OpenAI adjusts its video strategy, Sam Altman is setting his sights on the more ambitious field of "multi-agent systems." According to The Wall Street Journal, OpenAI has secretly invested in Isara, an AI startup founded by 23-year-old researchers Eddie Zhang and Henry Gasztowtt. Despite being established only in June last year in San Francisco, Isara has already recruited over a dozen top researchers from Google, Meta, and OpenAI itself, forming a highly skilled technical team. Isara’s core vision is to develop a system that enables thousands of AI agents to collaborate efficiently. While individual AI assistants are powerful, they often struggle with large-scale industrial challenges such as biotech R&D or complex financial modeling. Isara aims to solve this by creating a framework where diverse AI agents can communicate, align goals, share data, and tackle interconnected problems—functioning like a coordinated "robot army." This multi-agent approach is seen as a critical step toward Artificial General Intelligence (AGI). OpenAI’s endorsement signals industry recognition of distributed intelligence. In biopharma, the system could simulate thousands of protein-folding pathways, with specialized agents identifying patterns. In finance, it could perform real-time stress tests using global market data. Led by young innovators, this shift suggests the next breakthrough in AI lies not in building larger models, but in enabling smarter collective intelligence.

marsbit03/26 02:32

OpenAI Bets on 'Robot Army': 23-Year-Old Prodigy Wins Favor from Sam Altman

marsbit03/26 02:32

活动图片